📰 Dan Forche News
Page 3 - Dan Forche News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dan Forche. Real-time updates on events, politics, business and more.
March 22, 2022
/PRNewswire/-- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that...
February 3, 2022
PreludeDx™ Announces the Appointment of Derek J. Maetzold of Castle Biosciences to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace
February 2, 2022
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that...
December 7, 2021
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced the...
December 2, 2021
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today it...
December 2, 2021
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today it...
November 2, 2021
DCISionRT and its Response Subtype Identifies DCIS Patients with Unacceptably Elevated Risk of Local Recurrence after Breast Conserving Surgery and Radiation Therapy
October 27, 2021
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, presented data in an...
October 19, 2021
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today...
October 19, 2021
/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today...